Monday, 20 May 2019

BioTech News

  • Sandoz launches trial with Amgen biosimilar

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel. With this, Novartis has consolidated its leading position in...Read more

  • Life Tech, SGC to pioneer epigenetic antibody technology

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

    Singapore: Life Technologies signed a collaborative partnership with the Structural Genomics Consortium (SGC) and scientists in antibody technology at the Universities of Chicago and Toront...Read more

  • Calgary Scientific expands into China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    Singapore: Calgary Scientific, a company known for creating transformative technology, is continuing to revolutionize global healthcare by expanding into Asia. Calgary Scientific hired Mr R...Read more

  • WuXi, OMT join hands to develop OmniRat antibodies

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US, and Open Monoclonal Technol...Read more

  • Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

  • A*STAR Scientists Discover Potential Drug for Deadly Brain Cancer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults - glioblastoma multiforme. The scientists found that by targeting this biomarker...Read more

  • Early Hep B treatment effective in clearing virus

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London, have discovered that children and young patients with...Read more

  • Indo-Aussie research to find ovarian cancer cure

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • Japan scientists pioneer new stem cell technology

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • joimax goes BRIC and beyond

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more

  • NIH develops groundbreaking dengue vaccine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jan, 2013

    Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has generated a strong immune response. The early-stage clinical trial wa...Read more

  • Malvern acquires nanoparticle firm NanoSight

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: UK-based Malvern Instruments, a leading global provider of instrumentation and expertise for materials and biophysical characterization, has acquired nanoparticle characterizatio...Read more

  • Ambrx partners with WuXi to advance breast cancer treatement

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: In an effort to advance its breast cancer treatment, Ambrx has now partnered with WuXi PharmaTech and a Chinese drugmaker. As per the deal, Ambrx and Zhejiang Medicine will co-d...Read more

  • Thermo Fisher opens new facility in China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Thermo Fisher Scientific, the world leader in serving science, announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consum...Read more

  • Arno finds way to identify breast cancer receptor

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Arno Therapeutics, a US-based clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, has identified a new immunohistochemistry technique fo...Read more

  • Trial begins for vaccine that builds gluten tolerance

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

  • Skin cancer promoting gene discovered

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2012

    Singapore: Researchers from the University of Zurich have discovered a gene that plays a central role in black skin cancer or melanoma. Suppressing this gene in mice inhibits the developmen...Read more

  • Report: Taiwan is 3rd best country to invest in the world

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: Taiwan stands second in the ranking of best investment environment in Asia and third in the world racing behind Singapore and Switzerland, according to a report titled 'Evaluatio...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls